Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: Application to an original model of rheumatoid arthritis

Human Gene Therapy

Volumn 15, Issue 6, 2004, Pages 588-596

  Lin, Yea Lih ^a   Noël, Danièle ^b   Mettling, Clément ^a   Réant, Brigitte ^a,c   Clot, Jacques ^c   Jorgensen, Christian ^b   Corbeau, Pierre ^a,c  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b INSERM   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE EROSION; CARTILAGE CELL; CELL PROLIFERATION; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FELINE IMMUNODEFICIENCY VIRUS; GENE TARGETING; GENETIC TRANSDUCTION; KNEE; MOUSE; NONHUMAN; RHEUMATOID ARTHRITIS; SCID MOUSE; SYNOVIOCYTE; TITRIMETRY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; BONE; CARTILAGE; CYTOLOGY; DISEASE MODEL; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; SYNOVIUM; VIROLOGY;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; UNGULATA;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE AND BONES; CARTILAGE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MICE; MICE, SCID; SYNOVIAL MEMBRANE; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10944233388     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303404323142033     Document Type: Article

References (32)

1. AKKINA, R.K., WALTON, R.M., CHEN, M.L., LI, Q.X., PLANELLES, V., and CHEN, I.S. (1996). High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70, 2581-2585.
2. BRAY, M., PRASAD, S., DUBAY, J.W., HUNTER, E., JEANG, K.T., REKOSH, D., and HAMMARSKJOLD, M.L. (1994). A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. U.S.A. 91, 1256-1260.
3. BROWNING, M.T., SCHMIDT, R.D., LEW, K.A., and RIZVI, T.A. (2001). Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J. Virol. 75, 5129-5140.
4. BROWNING, M.T., MUSTAFA, F., SCHMIDT, R.D., LEW, K.A., and RIZVI, T.A. (2003). Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J. Gen. Virol. 84, 621-627.
5. BRUNNER, D., and PEDERSEN, N.C. (1989). Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J. Virol. 63, 5483-5488.
6. BUCALA, R., RITCHLIN, C., WINCHESTER, R., and CERAMI, A. (1991). Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 173, 569-574.
7. CHO, M.L., KIM, W.U., MIN, S.Y., MIN, D.J., MIN, J.K., LEE, S.H., PARK, S.H., CHO, C.S., and KIM, H.Y. (2002). Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor α production by rheumatoid synoviocytes. Arthritis Rheum. 46, 42-51.
8. CORBEAU, P., KRAUS, G., and WONG-STAAL, F. (1998). Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system. Gene Ther. 5, 99-104.
9. CURRAN, M.A., KAISER, S.M., ACHACOSO, P.L., and NOLAN, G.P. (2000). Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol. Ther. 1, 31-38.
10. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. U.S.A. 85, 6460-6464.
11. GOLDMAN, M.J., LEE, P.S., YANG, J.S., and WILSON, J.M. (1997). Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 8, 2261-2268.
12. GOUZE, E., PAWLIUK, R., PILAPIL, C., GOUZE, J.N., FLEET, C., PALMER, G.D., EVANS, C.H., LEBOULCH, P., and GHIVIZZANI, S.C. (2002). In vivo gene delivery to synovium by lentiviral vectors. Mol. Ther. 5, 397-404.
13. IKEDA, Y., TOMONAGA, K., KAWAGUCHI, Y., KOHMOTO, M., INOSHIMA, Y., TOHYA, Y., MIYAZAWA, T., KAI, C., and MIKAMI, T. (1996). Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells. J. Gen. Virol. 77(Part 8), 1623-1630.
14. JOHNSTON, J.C., GASMI, M., LIM, L.E., ELDER, J.H., YEE, J.K., JOLLY, D.J., CAMPBELL, K.P., DAVIDSON, B.L., and SAUTER, S.L. (1999). Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73, 4991-5000.
15. JORGENSEN, C., APPARAILLY, F., COURET, I., CANOVAS, F., JACQUET, C., and SANY, J. (1998). Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology 93, 518-523.
16. KAFRI, T., BLOMER, U., PETERSON, D.A., GAGE, F.H., and VERMA, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17, 314-317.
17. KAYE, J.F., and LEVER, A.M. (1999). Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J. Virol. 73, 3023-3031.
18. KEMLER, L. BARRAZA, R., and POESCHLA, E.M. (2002). Mapping the encapsidation determinants of feline immunodeficiency virus. J. Virol. 76, 11889-11903.
19. KOBINGER, G.P., WEINER, D.J., YU, Q.C., and WILSON, J.M. (2001). Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19, 225-230.
20. LOIS, C., HONG, E.J., PEASE, S., BROWN, E.J., and BALTIMORE, D. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868-872.
21. MAZARAKIS, N.D., AZZOUZ, M., ROHLL, J.B., ELLARD, F.M., WILKES, F.J., OLSEN, A.L., CARTER, E.E., BARBER, R.D., BABAN, D.F., KINGSMAN, S.M., KINGSMAN, A.J., O'MALLEY, K., and MITROPHANOUS, K.A. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121.
22. MIYOSHI, H., TAKAHASHI, M., GAGE, F.H., and VERMA, I.M. (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 94, 10319-10323.
23. NAFFAKH, N., PINSET, C., MONTARRAS, D., LI, Z., PAULIN, D., DANOS, O., and HEARD, J.M. (1996). Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum. Gene Ther. 7, 11-21.
24. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996a). Efficient transfer, integration, and sustained long-term expression of the transgenc in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
25. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996b). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
26. POESCHLA, E.M., WONG-STAAL, F., and LOONEY, D.J. (1998). Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4, 354-357.
27. RIZVI, T.A., SCHMIDT, R.D., and LEW, K.A. (1997). Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Virology 236, 118-129.
28. TOCHIKURA, T.S., TANABE-TOCHIKURA, A., HAYES, K.A., LAZO, A., BAILER, R.T., BLAKESLEE, J.R., Jr., LAFRADO, L.J., ROY-BURMAN, P., PANDEY, R., OLSEN, R.G., et al. (1993). Fusion activity dissociated from replication ability in feline immunodeficiency virus (FIV) in human cells. J. Acquir. Immune Defic. Syndr. 6, 1301-1310.
29. WHITWAM, T., PERETZ, M., and POESCHLA, E. (2001). Identification of a central DNA flap in feline immunodeficiency virus. J. Virol. 75, 9407-9414.
30. ZENNOU, V., PETIT, C., GUETARD, D., NERHBASS, U., MONTAGNIER, L., and CHARNEAU, P. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173-185.
31. ZENNOU, V., SERGUERA, C., SARKIS, C., COLIN, P., PERRET, E., MALLET, J., and CHARNEAU, P. (2001). The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19, 446-450.
32. ZHANG, H.G., HUANG, N., LIU, D., BILBAO, L., ZHANG, X., YANG, P., ZHOU, T., CURIEL, D.T., and MOUNTZ, J.D. (2000). Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Arthritis Rheum. 43, 1094-1105.